Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (4,547,770)	$ (5,555,524)	$ (9,804,798)	$ (9,074,964)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	42,297	92,771	85,034	184,964
Amortization of intangible assets			6,834	93,410
Amortization of deferred license costs			30,589	20,393
Amortization of debt issuance costs and debt discount			1,612,377	411,811
Amortization of right of use asset			761,767	428,934
Common stock issued for services				484,825
SG DevCorp equity transactions			2,846,013
Interest income on long-term note receivable				(18,699)
Stock-based compensation			527,336	3,210,631
Changes in operating assets and liabilities:
Accounts receivable			(181,602)	634,195
Contract assets			(102,256)	(835,925)
Inventories			(66,890)	(357,575)
Prepaid expenses and other current assets			293,112	(239,441)
Intangible assets			(211,651)	(92,005)
Accounts payable and accrued expenses			157,720	3,016,961
Contract liabilities			370,396	(268,479)
Lease liability			(942,264)	(653,213)
Assumed liability				15,000
Net cash used in operating activities			(4,618,283)	(3,039,177)
Cash flows from investing activities:
Purchase of property, plant and equipment			(8,229)	(526,324)
Cash from business combination			1,082
Project development costs			(184,991)	(117,682)
Investment in and advances to equity affiliates				(25,000)
Net cash used in investing activities			(192,138)	(669,006)
Cash flows from financing activities:
Repayment of short term notes payable			(1,588,001)	(2,500,000)
Proceeds from short-term notes payable and warrants, net of debt issuance costs			3,284,277	6,609,512
Proceeds from long-term notes payable				706,359
Purchase of treasury stock				(42,716)
Proceeds from warrant inducement			494,213
Prefunded warrant exercise			15
Issuance of common stock			3,619,253
Distribution paid to non-controlling interest				(46,417)
Net cash provided by financing activities			5,809,757	4,726,738
Net increase in cash and cash equivalents			999,336	1,018,555
Cash and cash equivalents - beginning of period			17,448	582,776	$ 582,776
Cash and cash equivalents - end of period	$ 1,016,784	$ 1,601,331	1,016,784	1,601,331	$ 17,448
Supplemental disclosure of non-cash investing and financing activities:
Cashless warrant exercise			114
Fractional common share adjustment			1
Common stock deemed dividend			670,881
Conversion of short-term notes payable to common stock			1,872,742
Prepaid interest for short-term notes payable			1,000,000
Common stock issuance for asset acquisition			228,360
Comon stock issuance for accounts payable settlement			489,268
Assets and liabilities acquired in business combination [Abstract]
Intangible assets			100,468
Goodwill			1,810,787
Accounts payable and accrued expenses			532,337
Contingent consideration payable			$ 945,000